Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading GALE News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||1.30%||83.34||1.8%||$745.39m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.39%||349.23||3.1%||$325.50m|
|ALXN||Alexion Pharmaceuticals, Inc.||2.27%||116.76||2.5%||$311.51m|
|VRTX||Vertex Pharmaceuticals Incorporated||1.20%||86.02||2.6%||$133.88m|
|BMRN||BioMarin Pharmaceutical Inc.||-0.73%||77.80||4.0%||$128.97m|
|A||Agilent Technologies, Inc.||1.35%||44.35||1.0%||$104.36m|
|SRPT||Sarepta Therapeutics, Inc.||2.20%||19.07||49.4%||$104.18m|
|EXAS||Exact Sciences Corporation||8.50%||12.25||21.4%||$102.22m|
|ACAD||ACADIA Pharmaceuticals Inc.||0.25%||32.46||19.6%||$95.68m|
Galena Biopharma, Inc. engages as a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs. It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral (fentanyl) sublingual tablets and Zuplenz (ondansetron) oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.